WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
NX-5948 has received fast track designation for relapsed or refractory Waldenström macroglobulinemia after prior BTK inhibitor therapy. The phase 1a/1b trial of NX-5948 shows a 77.8% objective ...
Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...
The novel treatment elritercept received a Fast Track designation from the FDA to treat anemia in patients with MDS. For patients with lower-risk myelodysplastic syndromes (MDS), the Food and Drug ...
Nearly 20 years ago, scientists stunned the world when they announced they had decoded the genes that make up a human being. As we first reported last March, they hoped to use that genetic blueprint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results